Pepper Bio hopes to challenge Eroom’s law with new funding

  • Post category:Blog

Whether you are a tech optimist or not, you have to acknowledge that progress rarely follows a straight line. While the world keeps getting better at churning semiconductors, we are still struggling to find new drugs to treat resistant diseases, and the process isn’t getting cheaper.

Some hope that AI can help, and it likely will — when it comes to biotech, it is much more than a buzzword.  But Boston-based drug discovery startup Pepper Bio fell in love with another term: Transomics. Calling itself “the world’s first transomics company,” it hopes that this approach will bring solutions for those suffering from untreated diseases such as certain forms of cancer.

Read on to learn how Pepper is changing drug discovery.

Source: TechCrunch // See original post here.